Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Stavudine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for stavudine and what is the scope of stavudine freedom to operate?

is the generic ingredient in three branded drugs marketed by Bristol Myers Squibb, Cipla Ltd, Hetero Labs Ltd Iii, Mylan, Aurobindo Pharma, and Mylan Labs Ltd, and is included in nine NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for stavudine. Eight suppliers are listed for this compound. There are ten tentative approvals for this compound.

Summary for Generic Name: stavudine

Drug Master File Entries: see list14
Suppliers / Packagers: see list8
Bulk Api Vendors: see list76
Clinical Trials: see list17
Patent Applications: see list5,818
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:stavudine at DailyMed

Tentative approvals for STAVUDINE

Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET; ORAL40MG; 150MG; 200MG
► Subscribe► SubscribeTABLET; ORAL40MG; 150MG
► Subscribe► SubscribeTABLET; ORAL40MG; 150MG; 200MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
CAPSULE;ORAL077672-002Dec 29, 2008ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma
CAPSULE;ORAL077672-001Dec 29, 2008ABRXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
CAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002DISCNNoNo7,135,465*PED► SubscribeY► Subscribe
Bristol Myers Squibb
FOR SOLUTION;ORAL020413-001Sep 6, 1996AARXYesYes► Subscribe► Subscribe
Bristol Myers Squibb
CAPSULE;ORAL020412-004Jun 24, 1994ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus